Imperial College London

Dr Benjamin Mullish

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

NIHR Clinical Lecturer







Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus





Benjamin Mullish is a NIHR Academic Clinical Lecturer in the Department of Metabolism, Digestion and Reproduction at Imperial College London and a Post-CCT fellow in Gastroenterology and Hepatology at St Mary's Hospital, Imperial College Healthcare NHS Trust.  He completed his PhD at Imperial College London (funded by a MRC Clinical Research Training Fellowship), and was previously an Imperial NIHR-funded Academic Clinical Fellow.

Selected Publications

Journal Articles

Yip AYG, King OG, Omelchenko O, et al., 2023, Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites, Nature Communications, Vol:14

Routy B, Lenehan JG, Miller WH, et al., 2023, Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial, Nature Medicine, Vol:29, ISSN:1078-8956, Pages:2121-2132

Ghani R, Mullish BH, McDonald JAK, et al., 2021, Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms, Clinical Infectious Diseases, Vol:72, ISSN:1058-4838, Pages:1444-1447

Mullish BH, Michael DR, McDonald JA, et al., 2021, Identifying the factors influencing outcome in probiotic studies in overweight and obese patients: host or microbiome?, Gut, Vol:70, Pages:225-226

Allegretti JR, Kelly CR, Grinspan A, et al., 2020, Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection, Gastroenterology, Vol:159, ISSN:0016-5085, Pages:1982-1984

Ianiro G, Mullish BH, Kelly CR, et al., 2020, Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic, Gut, Vol:69, ISSN:0017-5749, Pages:1555-1563

Mullish BH, McDonald JAK, Pechlivanis A, et al., 2019, Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent <i>Clostridioides difficile</i> infection, Gut, Vol:68, ISSN:0017-5749, Pages:1791-1800

Allegretti JR, Mullish BH, Kelly C, et al., 2019, The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications., Lancet, Vol:394, Pages:420-431

McDonald JAK, Mullish BH, Pechlivanis A, et al., 2018, Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota., Gastroenterology, Vol:155, Pages:1495-1507.e15

Mullish BH, Quraishi MN, Segal JP, et al., 2018, The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines., Gut, Vol:67, Pages:1920-1941

Dhar A, Mullish BH, Thursz MR, 2017, Grand round: anticoagulation in chronic liver disease, Journal of Hepatology, Vol:66, ISSN:1600-0641, Pages:1313-1326

Mullish BH, Marchesi JR, Thursz MR, et al., 2015, Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection., Qjm, Vol:108, Pages:355-359

Mullish BH, 2014, Case 25-2014: A man with ulcerative colitis and bloody diarrhea., New England Journal of Medicine, Vol:371, ISSN:0028-4793

Mullish BH, Kabir MS, Thursz MR, et al., 2014, Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation, Alimentary Pharmacology & Therapeutics, Vol:40, ISSN:0269-2813, Pages:880-892

More Publications